Skip to main content
Premium Trial:

Request an Annual Quote

HTG to Analyze Gene Expression for Takeda Pharmaceutical

NEW YORK, Sept. 22 (GenomeWeb News) - HTG will provide gene expression analysis services to Takeda Pharmaceutical of Japan, HTG said today.


Under the agreement, Tucson, Ariz.-based HTG will use its ArrayPlate technology to analyze samples provided by Takeda, which is based in Osaka.


HTG's ArrayPlate contains a Universal Array in each well of a 96-well microplate. The arrays can be programmed using HTG's reagents for the simultaneous measurement of DNA and RNA from the same sample. The assays rely on a quantitative nuclease protection assay.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.